Brain wave monitor tested during surgery sedation
NCT ID NCT07468162
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will monitor brain wave patterns in 48 adults undergoing orthopedic surgery under sedation with one of three drugs: remimazolam, dexmedetomidine, or midazolam. Researchers aim to see how these drugs change brain activity from the start of sedation through recovery. The goal is to better understand the unconscious state and improve monitoring during surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remimazolam, dexmedetomidine, or midazolam
What this could lead to
If successful, this could help doctors better understand how different sedatives affect brain activity during surgery, potentially improving anesthesia monitoring.
What could go wrong
This is a small, early-stage observational study with only 48 participants. It is not designed to test treatment effectiveness, and results may not apply to all patients or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORTHOPEDIC SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••